2,912 matches for your search in the start-up spotlight
rss
The successful digitization of products and processes is becoming a decisive factor for corporate success. Unamera is an Internet platform that focuses on the digital transformation of business processes and their integration in a horizontal and vertical direction. The primary goal is to achieve ...
ImevaX, based in Munich, Germany, is a biopharmaceutical company specializing in the development, manufacture and worldwide distribution of Pylori DuoTect®. Pylori DuoTect® is a highly effective and cost-efficient in vitro rapid test for the qualitative determination of specific antibodies ...
Amal Therapeutics SA is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Amal was incorporated on September 3rd 2012 and secured seed funding in February 2014 to establish and validate its technology platform. Boehringer Ingelheim Venture Fund led this ...
Immunic AG is a start-up biotech company founded in April 2016 and focused on the development of orally available, small molecule immune modulators to block immune and autoimmune responses. Immunic develops drug candidates until clinical proof of concept. Immunic, with headquarters in ...
Oculyze is a multi-award winning startup that develops individualized image recognition solutions. With our system, consisting of a smartphone microscope and automated image recognition, we enable microscopic images to be captured and analyzed within seconds; wherever you are. You don't need ...
Codecheck's vision is to help people find healthy and sustainable products that fit their individual needs. To achieve this goal, Codecheck offers an independent product check for food, household products and cosmetics. This checks via app or web whether a product is healthy, socially and ...
Nouscom is a private oncology company developing next generation immunotherapies. Nouscom's proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an ...
BioXpress Therapeutics SA is a privately held biotechnology company committed to developing high quality and cost-competitive biosimilars for unmet need indications such as cancer, inflammation and autoimmunity. Headquartered in Geneva, Switzerland, BioXpress Therapeutics business is focused on ...
